You have 9 free searches left this month | to do more
Showing 1 - 25 of
1,224 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
Z
Active, not recruiting
  • Abiraterone Acetate
  • +4 more
  • Abiraterone acetate tablets
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
2021-12-30
Dec 30, 2021
T
Completed
  • Healthy Volunteers
  • Abiraterone acetate tablets(Zecke ®250 mg);Abiraterone acetate tablets(250 mg)
  • Qingdao, Shangdong, China
    Phase I Clinical Research Center
2021-04-26
Apr 26, 2021
F
Completed
  • Prostate Cancer
  • AA Reduced dose-normal diet (A)
  • +2 more
  • Seville, Spain
    Hospital Universitario Virgen del Rocío
2021-01-08
Jan 8, 2021
A
Active, not recruiting
  • Prostate Cancer
  • Abiraterone acetate standard dose
  • Abiraterone acetate escalated dose
  • Paris, France
    Department of Medical Oncology, Cochin Hospital
2021-06-26
Jun 26, 2021
M
Active, not recruiting
  • Prostate Cancer
  • Boston, Massachusetts
    Massachusetts General Hospital
2021-02-08
Feb 8, 2021
W
Not yet recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • Drug Therapy, Combination
  • TQB3616 Capsules Combined With Abiraterone Acetate Plus Prednisone
  • Chengdu, Sichuan, China
    West China Hospital
2021-12-12
Dec 12, 2021
A
Active, not recruiting
  • Prostatic Neoplasms
  • Metastatic Castration-Resistant Prostate Cancer
  • Abiraterone Acetate
  • +2 more
  • Los Angeles, California
  • +6 more
2021-12-02
Dec 2, 2021
U
Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +6 more
  • Abiraterone Acetate
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2021-12-15
Dec 15, 2021
F
Completed
  • Salivary Glands Tumors
  • Abiraterone acetate
  • Milan, Lombardy, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
2021-03-01
Mar 1, 2021
J
Recruiting
  • Metastatic Castration-resistant Prostate Cancer (mCRPC)
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
2021-05-10
May 10, 2021
C
Completed
  • Pharmacogenetic Study
  • Abiraterone Acetate
  • Nice, France
    Centre Antoine Lacassagne
2020-12-03
Dec 3, 2020
U
Completed
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Abiraterone Acetate
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2021-04-22
Apr 22, 2021
D
Active, not recruiting
  • Prostate Cancer
  • La Jolla, California
  • +3 more
2021-09-01
Sep 1, 2021
M
Active, not recruiting
  • Prostate Cancer
  • Abiraterone acetate 1000 mg po daily
  • +2 more
  • New York, New York
  • +3 more
2021-09-01
Sep 1, 2021
J
Completed
  • Metastatic Castration-resistant Prostate Cancer
  • Metastatic Breast Cancer
  • Aurora, Colorado
  • +21 more
2021-07-22
Jul 22, 2021
U
Withdrawn
  • Prostatic Neoplasms, Castration-Resistant
  • (no location specified)
2020-11-15
Nov 15, 2020
W
Not yet recruiting
  • Prostate Cancer
  • Abiraterone acetate
  • +2 more
  • Chengdu, Sichuan, China
    West China Hospital
2021-02-03
Feb 3, 2021
I
Recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • Bellinzona, Switzerland
  • +6 more
2020-12-24
Dec 24, 2020